Potential Therapeutic Effects of the Neural Stem Cell-Targeting Antibody Nilo1 in Patient-Derived Glioblastoma Stem Cells

Glioblastoma (GBM) is the most devastating and least treatable brain tumor with median survival <15 months and extremely high recurrence rates. Promising results of immune checkpoint blockade obtained from pre-clinical studies in mice did not translate to clinic, and new strategies are urgently n...

Descripción completa

Detalles Bibliográficos
Autores principales: Rackov, Gorjana, Iegiani, Giorgia, Uribe, Daniel, Quezada, Claudia, Belda-Iniesta, Cristóbal, Escobedo-Lucea, Carmen, Silva, Augusto, Puig, Pere, González-Rumayor, Víctor, Ayuso-Sacido, Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468525/
https://www.ncbi.nlm.nih.gov/pubmed/32974206
http://dx.doi.org/10.3389/fonc.2020.01665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468525/
https://www.ncbi.nlm.nih.gov/pubmed/32974206
http://dx.doi.org/10.3389/fonc.2020.01665

Ejemplares similares